Cefotaxime Articles

Sanofi and Chugai to end marketing deal

6 August 2007

India revises 22 bulk drug prices

2 June 2003

Lupin files challenge to Roche's Rocephin in USA

29 April 2002

Chinese retail drug sales "up 30% to $2.5 billion in 2000, will hit $7

27 February 2001

India's drug pricing authority to be probed

3 October 2000

Local demand boosts Indian pharma firms

2 February 1999

Hoechst/Rhone-Poulenc Merger Looks More Likely

17 November 1998

Hoechst Sales Down 18% But HMR Pipeline Strong

19 August 1998

Lupin Set To Make Acquisition In USA

3 June 1998

Lupin Prepares To Bloom Globally

21 May 1998

Bad Times Soon Over, Says Hoechst Marion Roussel

12 March 1998

Max-GB To Double Penicillin Output

4 December 1997

India: "Price Control On 75 More Drugs"

7 October 1997

Roussel Uclaf Feels Currency Effects In 1995

26 February 1996

Roussel Uclaf Sees Pharma Focus Strategy Paying Off

5 June 1995

MMD Essential To Hoechst For Leading Pharma Role

3 April 1995

Stability, Consensus And Competition Needed In Germany

3 October 1994

Meropenem Effective For Bacterial Meningitis

22 August 1994

Hoechst Products to Be Boycotted In The USA

18 July 1994

ANTIBIOTICS IN SEPSIS INITIATION

27 June 1994

LIGHT AT THE END OF THE TUNNEL FOR HOECHST?

28 March 1994

LIKELY IMPACT ON DRUG FIRMS OF ITALIAN REFORMS

17 January 1994

PROFITS DIP AT ROUSSEL UCLAF

15 November 1993

VARIABLE RESISTANCE WITH CEPHALOSPORINS

8 November 1993

HOECHST PHARMA SALES ON THE SLIDE

25 October 1993

EARNINGS CLIMB AT ROUsSEL UCLAF

9 August 1993

ENCOURAGING RESULTS FOR ZENECA'S MERREM

5 July 1993

NEW LOMEFLOXACIN EFFICACY DATA

19 April 1993

ZENECA ANTIBIOTIC IN MENINGITIS STUDY

5 April 1993

HOECHST DISSATISFIED WITH 1992 RESULTS

29 March 1993

RESISTANCE ENSURES AUGMENTIN'S FUTURE

15 June 1992

Showing 1-31 of 31 articles

Go to beginningPrevious
  • 1
NextGo to end